Page 18 - Demo

5. A multidisciplinary team care approach improves outcomes in high-risk pediatric neuroblastoma patients. Chang HH, Liu YL, Lu MY, Jou ST, Yang YL, Lin DT, Lin KH, Tzen KY, Yen RF, Lu CC, Liu CJ, Peng SS, Jeng YM, Huang SF, Lee H, Juan HF, Huang MC, Liao YF, Lee YL, Hsu WM. Oncotarget. 2017 Jan 17;8(3):4360-4372. doi: 10.18632/oncotarget.13874.
6. Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma. Liu YL, Lu MY, Chang HH, Lu CC, Lin DT, Jou ST, Yang YL, Lee YL, Huang SF, Jeng YM, Lee H, Miser JS, Lin KH, Liao YF, Hsu WM, Tzen KY. Oncotarget. 2016 Apr 5;7(14):18774-86. doi: 10.18632/oncotarget.7933.
7. A Double Negative Loop Comprising ETV6/RUNX1 and MIR181A1 Contributes to Differentiation Block in t(12;21)-Positive Acute Lymphoblastic Leukemia. Yang YL, Yen CT, Pai CH, Chen HY, Yu SL, Lin CY, Hu CY, Jou ST, Lin DT, Lin SR, Lin SW.
PLoS One. 2015 Nov 18;10(11):e0142863. doi: 10.1371/journal.pone.0142863. eCollection 2015.
8. The long-term efficacy and tolerability of oral deferasirox for patients with transfusion- dependent β-thalassemia in Taiwan. Chang HH, Lu MY, Peng SS, Yang YL, Lin DT, Jou ST*, Lin
KH. Ann Hematol. 2015 Dec;94(12):1945-52.
9. GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma. Ho WL, Chou CH, Jeng YM, Lu MY, Yang YL, Jou ST, Lin DT, Chang HH, Lin KH, Hsu WM, Huang MC. Oncotarget. 2014 Dec 15;5(23):12247-59.
10. β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma. Chang HH, Chen CH, Chou CH, Liao YF, Huang MJ, Chen YH, Wang WJ, Huang J, Hung JS, Ho WL, Jeng YM, Che MI, Lee H, Lu MY, Yang YL, Jou ST, Lin DT, Lin KH, Hsu WM, Huang MC. Clin Cancer Res. 2013 Apr 1;19(7):1705-16. doi: 10.1158/1078-0432.CCR-12- 2367. Epub 2013 Feb 26.
11. Characterization of neuroblastic tumors using 18F-FDOPA PET. Lu MY, Liu YL, Chang HH, Jou ST, Yang YL, Lin KH, Lin DT, Lee YL, Lee H, Wu PY, Luo TY, Shen LH, Huang SF, Liao YF, Hsu WM, Tzen KY; National Taiwan University Neuroblastoma Study Group. J Nucl Med. 2013 Jan;54(1):42-9. doi: 10.2967/jnumed.112.102772. Epub 2012 Dec 4.
12. IKZF1 deletions predict a poor prognosis in children with B-cell progenitor acute lymphoblastic leukemia: a multicenter analysis in Taiwan. Yang YL, Hung CC, Chen JS, Lin KH, Jou ST, Hsiao CC, Sheen JM, Cheng CN, Wu KH, Lin SR, Yu SL, Chen HY, Lu MY, Wang SC, Chang HH, Lin SW, Su YN, Lin DT. Cancer Sci. 2011 Oct;102(10):1874-81. doi: 10.1111/j.1349-7006.2011.02031.x. Epub 2011 Aug 12.
13. Identification of variations in the human phosphoinositide 3-kinase p110delta gene in children with primary B-cell immunodeficiency of unknown aetiology. Jou ST, Chien YH, Yang YH, Wang TC, Shyur SD, Chou CC, Chang ML, Lin DT, Lin KH, Chiang BL. Int J Immunogenet. 2006 Oct;33(5):361-9.
14. Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex. Jou ST, Carpino N, Takahashi Y, Piekorz R, Chao JR, Carpino N, Wang D, Ihle JN. Mol Cell Biol. 2002 Dec;22(24):8580-91.
15. Phospholipase C gamma 2 is essential for specific functions of Fc epsilon R and Fc gamma R. Wen R, Jou ST, Chen Y, Hoffmeyer A, Wang D. J Immunol. 2002 Dec 15;169(12):6743-52.
16. Homozygous deletion of the p16INK4A gene occurs more frequently in CD2+ than in CD2+ T- cell acute lymphoblastic leukemia. Tien HF, Tang JL, Lee CF, Jou ST. Blood. 1998 Mar 1;91(5):1829- 30. No abstract available.
19